Salesforce vs CrowdStrike: One Stock Has the Clearer Path to Outperformance

Photo of Trey Thoelcke
By Trey Thoelcke Published

Quick Read

  • Salesforce edges CrowdStrike for retirement portfolios, backed by a 0.8% dividend, $25 billion buyback, and cleaner price target signal alignment heading into earnings.

  • Nvidia dominates headlines that same evening, but CrowdStrike's average post-earnings move of −1% and last quarter's −4% drop despite a beat signal real downside risk.

  • CrowdStrike's 26% revenue growth and ARR guidance raised 520 basis points still earn it a growth sleeve allocation, just not a retirement core.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Salesforce didn't make the cut. Grab the names FREE today.

Salesforce vs CrowdStrike: One Stock Has the Clearer Path to Outperformance

© 24/7 Wall St.

Salesforce (NYSE:CRM | CRM Price Prediction) and CrowdStrike (NASDAQ:CRWD) both step to the plate after the close on August 26, 2026, giving investors a same-session read on enterprise software and cybersecurity. Nvidia (NASDAQ:NVDA) reports the same evening and will draw much of the attention, but this other pair is the more actionable question for a retirement-focused portfolio. Which one deserves the core allocation heading into the report?

Analyst Consensus and Buy-Side Tilt

CRM analyst ratings
CRWD analyst ratings

Sell-side sentiment is the share of analysts recommending purchase versus caution. For Salesforce, 73% of analysts are bullish and 4% bearish. CrowdStrike carries a slightly heavier tilt with 77% bullish, 2% bearish. With more Strong Buy ratings, fewer skeptics, and higher conviction at the top of the book, CrowdStrike carries it. Winner: CrowdStrike.

Price Target and Implied Upside

Salesforce closed most recently at $205.69, against an analyst target of $243.98 and a 24/7 Wall St. model base case of $285.75 with 0.9 confidence and a Buy rating. The two signals point the same direction, with the model roughly one buffer above the Street. That is signal alignment.

CRM price target
CRWD price target

CrowdStrike is a different picture. The stock is at $185.38, the analyst target is $210.54, and the internal model sees a base case of $519.17 with a 180.06% upside label. That is a wide gap. When the sell-side consensus is hundreds of dollars below the quant target, that divergence is a disagreement flag. A retirement-focused reader should treat the eye-catching 180% number as a model output and weigh it against Wall Street. Salesforce’s signals line up cleanly, while CrowdStrike’s diverge sharply. Winner: Salesforce.

Setup Into the Report

Momentum favors Salesforce heading in. Its shares are up 4.9% over one week and 25.7% over one month, though still down 22.4% year to date and 17.0% over one year. That is a name recovering hard off a weak stretch, with a manageable beta of 1.152 and neutral Reddit sentiment on low activity.

CrowdStrike arrives at the report losing ground: down 12.9% over one week, up 1.2% over one month, and still up 58.2% year to date and 77.1% over one year. That is a strong runner slipping into the report, with a higher beta of 1.234.

History reinforces the caution: CrowdStrike’s average one-day post-earnings change is −0.9%, and last quarter delivered a −3.8% one-day move on a 2.8% beat. The lower-variance setup wins. Winner: Salesforce.

Verdict: Retirement Core Goes to Salesforce

Salesforce is the pick for a retirement-focused portfolio right now. It carries a real 0.8% dividend yield, recently raised, backed by a $25 billion accelerated share repurchase and a $50 billion authorization, alongside $6.556 billion in quarterly free cash flow and a raised fiscal 2027 revenue guide of $45.9 billion to $46.2 billion. Signal alignment on price targets and cleaner momentum seal it.

However, CrowdStrike earns genuine credit. Its 25.6% revenue growth, $255.8 million in net new ARR, and net new ARR guidance raised 520 basis points at the midpoint are best-in-class, and CEO George Kurtz’s line that “AI driving structural demand for cybersecurity that compounds, not decelerates” is a legitimate long-run thesis. The stock belongs in the growth sleeve.

The biggest risk to Salesforce is execution on management’s second-half acceleration story, with Tableau, commerce, and marketing softness as the drag. Watch cRPO growth, Agentforce ARR, and any change to the $14.06 to $14.12 non-GAAP EPS range. Those numbers set the tone for the next year of the stock.

 

Contact [email protected] for any questions or corrections.

Photo of Trey Thoelcke
About the Author Trey Thoelcke →

Trey has been an editor and author at 24/7 Wall St. for more than a decade, where he has published thousands of articles analyzing corporate earnings, dividend stocks, short interest, insider buying, private equity, and market trends. His comprehensive coverage spans the full spectrum of financial markets, from blue-chip stalwarts to emerging growth companies.

Beyond 24/7 Wall St., Trey has created and edited financial content for Benzinga and AOL's BloggingStocks, contributing additional hundreds of articles to the investment community. He previously oversaw the 24/7 Climate Insights site, managing editorial operations and content strategy, and currently oversees and creates content for My Investing News.

Trey's editorial expertise extends across multiple publishing environments. He served as production editor at Dearborn Financial Publishing and development editor at Kaplan, where he helped shape financial education materials. Earlier in his career, he worked as a writer-producer at SVE. His freelance editing portfolio includes work for prestigious clients such as Sage Publications, Rand McNally, the Institute for Supply Management, the American Library Association, Eggplant Literary Productions, and Spiegel.

Outside of financial journalism, Trey writes fiction and has been an active member of the writing community for years, overseeing a long-running critique group and moderating workshop sessions at regional conventions. He lives with his family in an old house in the Midwest.

Continue Reading

Top Gaining Stocks

MRNA Vol: 50,059,781
SMCI Vol: 48,195,311
CDW
CDW Vol: 1,764,150
CDNS Vol: 2,984,849
AMD
AMD Vol: 19,001,388

Top Losing Stocks

CTRA Vol: 73,319,495
ALB Vol: 2,271,504
Dow
DOW Vol: 9,178,020
LYB Vol: 3,664,898
ERIE Vol: 217,793